PFIZER INC Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
PFIZER INC (PFE) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 45.00 million shares for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-04
- PFIZER INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-28 was 45.00M shares, a 462.50% increase year-over-year.
- PFIZER INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-29 was 11.00M shares, a 35.29% decline year-over-year.
- PFIZER INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-28 was 8.00M shares, a 68.00% decline year-over-year.
- PFIZER INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-29 was 8.00M shares, a 65.22% decline year-over-year.
- PFIZER INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 11.00M shares, a 54.17% decline from fiscal 2024.
- PFIZER INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 24.00M shares, a 166.67% increase from fiscal 2023.
- PFIZER INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 9.00M shares, a 800.00% increase from fiscal 2022.
- PFIZER INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 1.00M shares, a 50.00% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-28 | 45.00M shares 10-Q · filed 2026-08-04 | 11.00M shares 10-Q · filed 2026-08-04 | ||
| 2026-03-29 | 11.00M shares 10-Q · filed 2026-05-05 | |||
| 2025-12-31 | 11.00M shares 10-K · filed 2026-02-26 | |||
| 2025-09-28 | 8.00M shares 10-Q · filed 2025-11-04 | 11.00M shares 10-Q · filed 2025-11-04 | ||
| 2025-06-29 | 8.00M shares 10-Q · filed 2026-08-04 | 12.00M shares 10-Q · filed 2026-08-04 | ||
| 2025-03-30 | 17.00M shares 10-Q · filed 2026-05-05 | |||
| 2024-12-31 | 24.00M shares 10-K · filed 2026-02-26 | |||
| 2024-09-29 | 25.00M shares 10-Q · filed 2025-11-04 | 25.00M shares 10-Q · filed 2025-11-04 | ||
| 2024-06-30 | 23.00M shares 10-Q · filed 2025-08-05 | 24.00M shares 10-Q · filed 2025-08-05 | ||
| 2024-03-31 | 26.00M shares 10-Q · filed 2025-05-05 | |||
| 2023-12-31 | 9.00M shares 10-K · filed 2026-02-26 | |||
| 2023-10-01 | 58.00M shares 10-Q · filed 2024-11-04 | 2.00M shares 10-Q · filed 2024-11-04 | ||
| 2023-07-02 | 3.00M shares 10-Q · filed 2024-08-05 | 2.00M shares 10-Q · filed 2024-08-05 | ||
| 2023-04-02 | 2.00M shares 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | 1.00M shares 10-K · filed 2025-02-27 | |||
| 2022-10-02 | 3.00M shares 10-Q · filed 2023-11-08 | 1.00M shares 10-Q · filed 2023-11-08 | ||
| 2022-07-03 | 1.00M shares 10-Q · filed 2023-08-09 | 0.00 shares 10-Q · filed 2023-08-09 | ||
| 2022-04-03 | 0.00 shares 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | 2.00M shares 10-K · filed 2024-02-22 | |||
| 2021-10-03 | 0.00 shares 10-Q · filed 2022-11-09 | 3.00M shares 10-Q · filed 2022-11-09 | ||
| 2021-07-04 | 5.00M shares 10-Q · filed 2022-08-10 | 4.00M shares 10-Q · filed 2022-08-10 | ||
| 2021-04-04 | 2.00M shares 10-Q · filed 2022-05-11 | |||
| 2020-12-31 | 4.00M shares 10-K · filed 2023-02-23 | |||
| 2020-09-27 | 7.00M shares 10-Q · filed 2021-11-12 | 5.00M shares 10-Q · filed 2021-11-12 | ||
| 2020-06-28 | 6.00M shares 10-Q · filed 2021-08-12 | 4.00M shares 10-Q · filed 2021-08-12 | ||
| 2020-03-29 | 3.00M shares 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | 2.00M shares 10-K · filed 2022-02-24 | |||
| 2019-09-29 | 3.00M shares 10-Q · filed 2020-11-05 | 2.00M shares 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | 1.00M shares 10-Q · filed 2020-08-06 | 2.00M shares 10-Q · filed 2020-08-06 | ||
| 2018-12-31 | 2.00M shares 10-K · filed 2021-02-25 | |||
| 2014-06-29 | 44.00M shares 10-Q · filed 2014-08-07 | 44.00M shares 10-Q · filed 2014-08-07 | ||
| 2014-03-30 | 43.00M shares 10-Q · filed 2014-05-08 | |||
| 2013-12-31 | 43.00M shares 10-K · filed 2014-02-28 | |||
| 2013-09-29 | 43.00M shares 10-Q · filed 2013-11-08 | 43.00M shares 10-Q · filed 2013-11-08 | ||
| 2013-06-30 | 44.00M shares 10-Q · filed 2014-08-07 | 44.00M shares 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | 97.00M shares 10-Q · filed 2014-05-08 | |||
| 2012-12-31 | 177.00M shares 10-K · filed 2014-02-28 | |||
| 2012-09-30 | 180.00M shares 10-Q · filed 2013-11-08 | 180.00M shares 10-Q · filed 2013-11-08 | ||
| 2012-07-01 | 216.00M shares 10-Q · filed 2013-08-09 | 216.00M shares 10-Q · filed 2013-08-09 | ||
| 2012-04-01 | 223.00M shares 10-Q · filed 2013-05-10 | |||
| 2011-12-31 | 272.00M shares 10-K · filed 2014-02-28 | |||
| 2011-10-02 | 342.00M shares 10-Q · filed 2012-11-09 | 279.00M shares 10-Q · filed 2012-11-09 | ||
| 2011-07-03 | 280.00M shares 10-Q · filed 2011-08-11 | 281.00M shares 10-Q · filed 2012-08-09 | ||
| 2011-04-03 | 290.00M shares 10-Q · filed 2012-05-10 | |||
| 2010-12-31 | 413.00M shares 10-K · filed 2013-02-28 | |||
| 2010-10-03 | 419.00M shares 10-Q · filed 2011-11-10 | 419.00M shares 10-Q · filed 2011-11-10 | ||
| 2010-07-04 | 427.00M shares 10-Q · filed 2011-08-11 | 427.00M shares 10-Q · filed 2011-08-11 | ||
| 2010-04-04 | 366.00M shares 10-Q · filed 2011-05-12 | |||
| 2009-12-31 | 400.00M shares 10-K · filed 2012-02-28 | |||
| 2009-09-27 | 406.00M shares 10-Q · filed 2010-11-12 | 406.00M shares 10-Q · filed 2010-11-12 | ||
| 2009-06-28 | 422.00M shares 10-Q · filed 2010-08-12 | 422.00M shares 10-Q · filed 2010-08-12 | ||
| 2008-12-31 | 489.00M shares 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |